← Back to Clinical Trials
Recruiting NCT06652321

NCT06652321 Endothelial Side Up Inverted Femtosecond Laser Assisted DSAEK

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06652321
Status Recruiting
Phase
Sponsor Dar El Oyoun Hospital
Condition Pseudophakic Bullous Keratopathy
Study Type INTERVENTIONAL
Enrollment 15 participants
Start Date 2022-01-01
Primary Completion 2024-11-30

Trial Parameters

Condition Pseudophakic Bullous Keratopathy
Sponsor Dar El Oyoun Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 15
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2022-01-01
Completion 2024-11-30
Interventions
Endothelial Side Up Femtosecond Laser Assisted DSAEK

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

To evaluate the clinical outcomes (pos toperative best corrected visual acuity, endothelial count) and anatomical results (interface smoothness) of DSAEK with Femto LDV-prepared grafts from the endothelial side.

Eligibility Criteria

Inclusion Criteria: Patients with Fuchs' endothelial dystrophy Patients with bullous keratopathy secondary to intraocular surgeries, iridocorneal endothelial syndrome, or viral keratitis Exclusion Criteria: Bullous keratopathy secondary to glaucoma or ocular trauma Corneal stromal scarring or opacities Diseases not affecting the corneal endothelium, including corneal ectasia (e.g., keratoconus, keratoglobus, pellucid marginal degeneration) Epithelial, Bowman layer/anterior stromal, and stromal dystrophies Hypotonic eyes Retinal diseases Any type of optic atrophy

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology